{
  "id": 657873,
  "title": "Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update",
  "url": "https://urgent.news/2026/08/12/arbutus-reports-second-quarter-2026-financial-results-and-provides",
  "topic": "world",
  "section": "World",
  "published": "2026-08-12T11:33:56.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/arbutus-reports-second-quarter-2026-financial-results-and-provides-corporate-update"
  },
  "original_language": "en",
  "account": null,
  "summary": "Maintained strong financial position with cash, cash equivalents and marketable securities of $92.6M as of June 30, 2026 Received first payment of approximately $178M from Moderna settlement in July and expects to return up to approximately $230M in capital to Arbutus shareholders Filed three international patent enforcement lawsuits against Pfizer and BioNTech related to lipid […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}